The retinoblastoma susceptibility gene was the first tumor suppressor gene identified in humans and the first tumor suppressor gene knocked out by targeted deletion in mice. RB serves as a transducer between the cell cycle machinery and promoter-specific transcription factors, its most documented activity being the repression of the E2F family of transcription factors, which regulate the expression of genes involved in cell proliferation and survival. Recent investigations of RB function suggest that it works as a fundamental regulator to coordinate pathways of cellular growth and differentiation. In this review, we unravel the novel role of an equally important aspect of RB in downregulating the differentiation inhibitor EID-1 during cellular differentiation by teasing apart the signal, which elicit differentiation and limit cell cycle progression, since the molecular mechanisms relating to RB activation of differentiation is much less understood. We review the various roles for RB in differentiation of neurons, muscle, adipose tissue, and the retina. In addition, we provide an update for the current models of the role of RB in cell cycle to entry and exit, extending the view toward chromatin remodeling and expose the dichotomies in the regulation of RB family members. We conclude with a discussion of a novel RB regulatory network, incorporating the dynamic contribution of EID family proteins.
Introduction
Extensive studies of the gene responsible for the heritable malignant childhood disease of the retina, the retinoblastoma gene, provided the first evidence for the presence of tumor suppressors in our genome in the early 1980s Cavenee et al., 1983; Cavenee et al., 1985) . Indeed, mutation of the retinoblastoma susceptibility (Rb) gene was found both in familial and sporadic retinoblastoma cases (Friend et al., 1986; Lee et al., 1987) . Yet the fascinating experiment in which reintroduction of a single copy of recombinant Rb cDNA to Rb deficient cancer cells repressed their tumorigenic potential in nude mice assays, ultimately led to the exciting key discovery that indeed, Rb is the first known human suppressor of tumors (Huang et al., 1988) . Intense studies in the past two decades support a central theme that the retinoblastoma gene product (RB protein) plays critical roles in regulating cell cycle progression and cellular differentiation. Its role in regulating the G1-phase of the cell cycle was confirmed by overexpression studies in which cells were microinjected with purified unphosphorylated RB protein during early G1-phase and resulted in reversible G1 arrest, while injection of similar amounts of RB in late G1-phase or early S-phase exhibited no effect on DNA synthesis (Goodrich et al., 1991) . This observation revealed a restriction point that is controlled by RB during the cell cycle transition from early G1-phase to late G1/S-phase, through which normal cells are committed to DNA synthesis and cell division (Flemington et al., 1993; Helin et al., 1993) . Thereafter, RB in complex with its sequence-specific DNA-binding trancription factor E2F (Nevins, 1992) , emerged as the key gatekeeper to restrain cell cycle progression by repressing the transcription of genes required for S-phase and DNA synthesis in addition to inhibiting cell cycle re-entry from quiescence in order to maintain a terminally differentiated state. By deduction, functional RB is therefore essential for proper cell cycle withdrawal during cellular differentiation although this detailed aspect of regulation by RB remains unclear. Regulation of RB by cyclin-dependent kinases is conserved among various cell types (Sherr, 1996) . However, the role of RB in cellular differentiation has been shown to display high tissue specificity that could involve cell type specific factors, as well as functionally redundant players like p107 and p130. This review extends the current understanding of the Rb tumor suppressor by examining its role as a regulator of cellular differentiation, presents new data suggesting its function in development, and provides future direction for studies concerning how RB maintains these roles in addition to safeguarding genomic integrity in the cell.
RB in development and differentiation

RB and Neurogenesis
A role for RB in mammalian development was first established after the demonstration that Rb À/À embryos die between days 13 and 15 of gestation (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . As deregulation of cell cycle progression and cellular differentiation play a critical role in tumorigenesis, it became evident that an alternative function of RB is to remove differentiation blocks that are set at certain stages of development to maintain the proper timing of differentiation through its specific interaction with the inhibitor of differentiation, Id2. Id2, a target of RB, is required to maintain the timing of differentiation in many processes of mammalian development and also serves as a positive regulator of cell cycle progression (Norton et al., 1998) . The unrestricted activation of Id2 underlies defects in differentiation of erythrocytes and neuronal cells of Rb knockout mice, presumably since the interaction between RB and Id2 is proposed to sequester Id2 (Iavarone et al., 1994) . The observed defects in neurogenesis and erythropoiesis caused by loss of Rb in the developing Rb À/À mouse embryo recapitulates the consequences of uncontrolled Id2 activity, as suggested by the observation that a null mutation of Id2 rescues defects and prolongs the life span of Rb À/À embryos (Lasorella et al., 2000) . These observations, in amalgamation to the increased prevalence of abnormal mitosis and apoptosis observed in the intermediate zones of the developing neural tube, coupled to a decrease in the expression of several neuronal markers, including neurotrophin receptors TrkA, TrkB, and p75, implicated a role for RB in neurogenesis . Later, to confirm this contention, using a neuronal specific promoter driving a LacZ reporter gene, widespread abnormalities in the developing nervous system was observed, including the olfactory epithelium, the retina, and the neocortex (Slack et al., 1998) . These studies suggested that RB is essential immediately following commitment to a neuronal fate. Interestingly, there is a high incidence of apoptosis in the extraembryonic tissues of the placenta. A provocative theory suggested that some of the abnormalities observed in Rb À/À embryos could be attributed to non-cell autonomous functions, since the supply with normal placenta to Rb À/À embryos demonstrated that they can reach full term, but die with severe problems in the skeletomuscular system . Additionally, a recent conditional mouse model with telencephalon-specific Rb deletions reveals a cellautonomous role of Rb in neuronal migration (Ferguson et al., 2005) .
RB and skeletal muscle system During muscle differentiation, it has been demonstrated that the mRNA and protein levels of Rb increase (Coppola et al., 1990) . Rb augments the activity of MyoD, an early muscle basic helix-loop-helix transcription factor important for muscle differentiation and cell cycle suppression, since the activity of MyoD-mediated transcriptional activation of certain myogenic genes requires functional RB (Gu et al., 1993) . Moreover, it was observed that inactivation of RB results in the inhibition of differentiation of myoblasts and myotubes in culture and accordingly, terminally differentiated myotubes reenter the cell cycle, while normal myoblasts enter a postmitotic state before differentiating into myotubes (Novitch et al., 1996; Zacksenhaus et al., 1996) . This observed phenomenon recapitulates earlier work, which postulated RB as a prerequisite for the establishment of the postmitotic state of skeletal muscle cells (Schneider et al., 1994) . This postulate was later supported by several animal studies demonstrating newborn mice lacking RB exhibit severe defects in skeletal muscle (Zacksenhaus et al., 1996; de Bruin et al., 2003; Wu et al., 2003) . In the absence of RB, skeletal muscle cells show ectopic DNA synthesis and/or apoptosis (Schneider et al., 1994; Novitch et al., 1996; Novitch et al., 1999) . To tease apart the molecular mechanism governing the steps of Rb expression during myogenesis, Delehouzee et al. have proposed a model involving GABP, a widely expressed erythroblast transformation specific transcription factor GA-binding protein that targets both nuclear-encoded mitochondrial proteins and neuromuscular-specific genes, YY1, a ubiquitous and multifunctional zincfinger transcription factor member of the Polycomb Group protein family which can both initiate and regulate transcription by activation or repression of target genes, and HCF-1, the abundant chromatinassociated human factor which is a heterodimeric complex essential for G1-phase progression and proper cytokinesis at the end of M-phase. In their study, they demonstrate before differentiation GABP and YY1 are present on the Rb promoter limiting the level of Rb expression. As cells advance through myogenesis, HCF-1 is recruited to, and YY1 is removed from, the promoter resulting in a sharp upregulation of Rb gene expression observed at day 2 of myogenesis (Delehouzee et al., 2005) . This model for RB regulated myogenic differentiation is further supported by earlier studies investigating the effect of Rb deletion before and after myogenic differentiation (Huh et al., 2004) . Myf5-cre;Rb floxed mice, which deletes RB in myoblasts, die immediately at birth with a characteristic phenotype exhibiting a high incidence of apoptosis and almost complete absence of myofibers. MCK-cre;Rb floxed mice, which deletes Rb in differentiated fibers, were viable and display normal muscle phenotype. Together, these studies suggest that RB is required for progression of differentiation and not for the maintenance of the differentiated state. In contrast, differentiated mouse hair cells with a conditional deletion of Rb are shown to be able to re-enter cell cycle and divide, while continuing to become highly differentiated and functional, suggesting that the requirement of RB for the maintenance of postmitotic state might be tissue specific (Mantela et al., 2005; Sage et al., 2005) .
RB and adipogenesis RB, p107, and p130, known collectively as pocket proteins due to a shared viral oncoprotein-binding domain (Ewen et al., 1991; Mayol et al., 1993) , regulate the cell cycle by restraining the G1-S transition through the reversible regulation of E2F-responsive genes (Flemington et al., 1993; Helin et al., 1993) , by inhibiting Cdk2, or by stabilizing p27-kip (Woo et al., 1997; Rodier et al., 2005) . Moreover, they are also implicated in the control of G0 exit (Hannan et al., 2000; Scott et al., 2001) , the spatial organization of replication (Barbie et al., 2004) , and genomic rereplication (Cobrinik, 2005) . Additionally they contribute to silencing of such genes in cells that are undergoing senescence or differentiation (Frolov and Dyson, 2004) . However, during adipogenesis opposing roles for RB and p130/ p107 has been demonstrated in which MEFs lacking Rb are unable to undergo adipose conversion in response to treatment with standard adipogenic inducers (Chen et al., 1996) and have general defects in their differentiation potential, while p107/p130-deficient cells display an increased differentiation potential (Classon et al., 2000) . It has been shown that Rb deficient MEFs or stem cells undergo differentiation preferentially into white adipocytes when the cells are treated with a PPAR-gamma ligand (Hansen et al., 2004) . Moreover, inactivation of the RB family by SV40 large T antigen displays similar defects in adipocyte differentiation (Higgins et al., 1996) . Adipocyte precursor cells give rise to two major cell populations with distinct physiological roles: white and brown. White adipose tissue stores energy, while brown adipose tissue dissipates energy through adaptive thermogenesis. Mice lacking p107 displayed a replacement of white adipose tissue with brown adipose tissue, which is mediated by the regulation of PGC-1 alpha . Cre-mediated deletion of Rb in adult primary preadipocytes blocked their differentiation into white adipocytes . These studies suggest, at least in vitro, that RB and its pocket proteins serve as a molecular switch that determines the pathway leading to brown or white adipocyte differentiation (Hansen et al., 2004) . Nevertheless, the underlying molecular mechanism largely remains unknown.
RB and retinal development
During retinal development, cell cycle exit and cell fate specification are coordinated to ensure that the adult retina forms appropriately, since the overall size of the retina and the proportion of each cell type contained therein is essential for proper vision. When cell proliferation and cell fate specification become uncoupled, visual processing is severely compromised and tumor formation ensues, as exemplified in the case of retinoblastoma. Importantly, loss of RB causes ectopic cell division in the retina, and even more severely in retinas deficient for both RB and p107. This phenotype is consistent with retinoblastoma development, which requires deletion of both Rb and p107 (RobanusMaandag et al., 1998) . Immunocytochemical studies suggested that retinoblastoma arises from death resistant inner nuclear layer precursors (Chen et al., 2004) , and implies that Rb À/À retinal cells that fail to commit to terminal differentiation, and not RB deficient cells prone to apoptosis, leads to oncogenic transformation. To tease apart the mechanism by which cells that lack RB undergo apoptosis or develop tumors, early studies using chimeric mice elucidated that Rb À/À cells provide a minor contribution to the adult retina (Maandag et al., 1994) , suggesting Rb À/À cells undergo apoptosis. To further support this observation, it was later shown that expression of E7, which binds RB, p107 and p130, induces cell death in the retina (Howes et al., 1994) , while expression of SV40T antigen, which binds RB family proteins and p53, results in tumor formation (Windle et al., 1990) . Taken together, these studies suggested that Rb À/À cells must escape apoptosis in the development of retinoblastoma (Classon and Harlow, 2002) . More recently, it was demonstrated that the laminar organization of retinas from Rb À/À embryos is severely disrupted which is caused by alteration in retinal cell fate specification and differentiation. Rb is expressed in proliferating retinal progenitor cells in the postnatal mouse retina and in differentiating rod photoreceptors, where it exerts two very distinct roles (Zhang et al., 2004) . In replicating progenitor cells, Rb is required for efficient cell cycle exit while in differentiating rods it is required for appropriate maturation (Dyer and Bremner, 2005) . In contrast to the role of Rb in other regions of the developing CNS, its dual role in these two retinal cell populations is cell autonomous.
RB forms a functional complex with Pax6, which is essential for lens formation (Cvekl et al., 1999) . It is expressed in lens progenitor cells before the onset of crystalline expression and it serves as an important regulatory factor required for expression of c-Maf, MafA/L-Maf, Six3, Prox1, and retinoic acid signaling both in lens precursor cells and the developing lens (Cvekl et al., 2004) . It was previously demonstrated using Pax 6 -cre, which is also active in peripheral retinal progenitors at embryonic day 10, that RB was inactivated in the developing retina and leads to a reduction in both ganglion and bipolar cells (Chen et al., 2004) . Therefore, this result in addition with the latter supports an important role for RB at the molecular level in specific neurons critical to their differentiation or survival.
The role of RB in cell cycle exit and entrance
Restriction point
The restriction point separates the G1-phase of continuously cycling cells into two functionally different parts: the first part represents the growth factor dependent postmitotic interval from mitosis to the restriction point and is constant in length (3-4 h), and the second part which represents the growth factor independent pre-S-phase interval of G1 that lasts from the restriction point to S-phase and varies in time (1 to 10 h) (Pardee, 1974; Dou et al., 1993) . The normal function of RB in regulating cellular growth can be elucidated from its undulating phosphorylation pattern which is tightly coupled to distinct phases of the cell cycle, and the inactivation of which may lead to unbridled cell growth. RB becomes hyperphosphorylated in late G1-phase, which is believed to cause its functional inactivation, and remains hyperphosphorylated in S-, G2-, and M-phases (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989) . Cells in G0/G1 express RB in an un-or hypophosphorylated form. The mechanism and significance of RB phosphorylation comes from the observation that certain cyclins, which are known to regulate the specificity and activity of cyclin-dependent kinases (cdk), trigger phosphorylation of RB and, as a result inhibit RB function (Sherr, 1996) . Injecting purified Rb protein into early G1 cells halts their progression into S-phase of the cell cycle. By contrast, late G1 cells are inert to Rb inhibition and continue progressing into S-phase (Goodrich et al., 1991) . This phenomenon is reminiscent of the growth factor requirement preceding the restriction point. Indeed, growth factors stimulate the expression of D-type cyclins which complex with Cdk 4, 6 to mediate the initial phosphorylation of the RB protein (Kato et al., 1993) and mitigates the repression of cyclin E transcription by Rb and, its tightly bound cellular transcription factor, E2F (Harbour et al., 1999) . E2F was originally identified on the basis of its involvement in adenovirus E2 gene transcription (Nevins, 1992) . It is required for transcription of cellular genes that participate in growth control and DNA synthesis and has been demonstrated to bind the hypophosphorylated form of RB (Hiebert et al., 1992; Johnson et al., 1993; Schwarz et al., 1993) . Thus, it is the hypophosphorylated RB species that curbs cell growth by binding E2F, thereby blocking its growth promoting activity. Phosphorylated RB or by complex with DNA viral oncoproteins, liberates E2F from RB and leads to transcriptional activation of growth promoting genes (Nevins, 1994; Taya, 1997) . Accumulation of cyclin E together with Cdk2 orchestrates the continued phosphorylation on RB protein and leads to the release of E2F, thereby facilitating the activation of genes critical for S-phase progression (Obeyesekere et al., 1995; Harbour and Dean, 2000) . Cyclin E-Cdk2 and cyclin A-Cdk2 also regulates centrosome duplication concomitantly with nuclear DNA replication (Hinchcliffe et al., 1999; Lacey et al., 1999) , whereas terminal differentiation requires the permanent withdrawal from the cell cycle and involves the repression of genes critical for S-phase entry. Therefore, the cellular response to functional Rb fundamentally depends on its status in the cell cycle.
RB and E2F
The RB/E2F complex consists of three RB like proteins (RB, p107, and p130), and six E2F family members (E2F -1, -2, -3, -4, -5, and -6) each of which can heterodimerize with two DNA-binding protein partners (DP1 and DP2) to form 12 different DNA-binding transcriptional regulators (Cam and Dynlacht, 2003) . The E2F family members share DNA-binding specificity since they bind to and regulate the promoters for genes whose products are important for cell cycle progression and DNA synthesis, however, they can be divided into two classes: activators (E2F1, E2F2, and E2F3) and repressors (E2F4 and E2F5) of transcription. E2F6 is considered to be an independent member that lacks several functional domains, including the cyclin-and pRb-binding domains and the trans-activation domain (Trimarchi et al., 1998) . Activator-E2Fs utilize RB as their major binding partner, while repressor-E2Fs bind p130, while p107 only binds preferentially to E2F-4 (Frolov and Dyson, 2004) . The p107, p130 pocket proteins repress transcription by counteracting E2F-mediated transactivation simply by binding to and masking the E2F activation domain or they can recruit corepressor complexes to E2F. Several of the complexes that have been linked to RB have enzymatic activities directed toward chromatin or recognize particular histone modifications suggesting that they impinge upon chromatin structure (Zhang and Dean, 2001) , which is supported by the previous finding that these protein complexes display a unique expression pattern during cell cycle progression (Shirodkar et al., 1992; Dyson, 1998; Nevins, 1998) . The RB/E2F complex can be detected in G1-phase and seems to play a critical role in the G1 to S transition. Activator-E2Fs exist in free form during S-phase. The p130/E2F complex is most evident in quiescent cells and the p107/E2F complex is present in both G1-and S-phase. Thus the question remains as to the exact physiological role of different RB/E2F complexes and of the factors that determine which RB/ E2F complex will bind to and regulate E2F response genes.
The E2F target genes E2F genes play a key role in the regulation of cyclin E expression and have provided some of the first mechanistic evidence of how mutation of RB leads to deregulated cell division. Deregulation of E2F family members gives rise to a variety of severe biological consequences (Trimarchi and Lees, 2002) . According to Wells et al. (2002) , loss or overexpression of E2F1 using transgenic mouse models has been linked to dysplasia and tumor formation in the liver, neoplasia of the skin, and tumors in the reproductive tract, lung and lymphatic system. The combined use of E2F1 nullizygous mice, oligonucleotide-based microarrays, and chromatin immunoprecipitation revealed that E2F target promoters were bound by multiple different E2Fs, the mRNA levels of target genes decrease in accordance with loss of E2F1 and, in addition, the observation that E2F1, and not other E2Fs, is bound to the proximal promoter regions in vivo highly suggests that specific genes are directly, and nonredundantly, regulated by E2F1. However, several of the promoters identified do not have a consensus E2F site implying that E2F1 can be recruited by other DNA-binding proteins to execute its regulatory function. Recently, using genome-wide microarray analysis of the proximal promoters of nearly1200 human genes, many new target genes of E2Fs have been identified (Ren et al., 2002) . Based on the results, it was implicated that besides regulating genes critical for cell cycle progression, E2F could govern the expression of genes required for DNA repair, chromatin assembly, condensation, and segregation, as well as multiple checkpoints that ensure genomic integrity. In another study, ChIP assays using an antibody to E2F4 to probe human CpG islands by microarray analysis, revealed many genes involved in DNA repair or recombination (Weinmann et al., 2002) . Collectively, these studies suggest that E2F targets include genes involved in chromatin structure and DNA replication/repair/recombination, and deregulation of these target genes could have profound effects on the integrity of the genome.
RB and chromatin modifiers RB and the E2F family genes are critical for cells to progress through G1-phase. How they control the expression of E2F response genes is under intense investigation. It was proposed that RB suppresses activator-E2Fs by directly binding to the activation domain (Flemington et al., 1993) (Helin et al., 1993) . In vitro transcription analysis revealed that RB blocks the assembly of preinitiation complexes (Ross et al., 1999) . Recently, a model has been proposed that RB family members recruit various chromatin modifiers to repress E2F response genes (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998; Robertson et al., 2000) (Nielsen et al., 2001; Vandel et al., 2001; Pradhan and Kim, 2002) . In the absence of growth stimuli, unphosphorylated RB family proteins bind E2F and recruit corepressors to enable factors that remodel chromatin at the E2F response promoter. These factors include, but are not limited to: histone deacetylases (HDACs) (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) , histone methyltransferases (Nielsen et al., 2001; Vandel et al., 2001) , and DNA methylases (Robertson et al., 2000; Pradhan and Kim, 2002) . The p130/E2F4 complex binds the E2F response promoter in resting cells (Moberg et al., 1996 ; see also Macaluso et al., in this Issue). By ChIP analysis, it was demonstrated that these promoters were also bound by HDACs, implying that genes regulated by E2F are repressed in early G1-phase through deacetylation on the nucleosomes (Takahashi et al., 2000; Wells et al., 2000; Ferreira et al., 2001; Taubert et al., 2004) . When cells transit through midG1 these E2F response promoters are occupied by activator-E2Fs. This replacement correlates with the dissociation of HDACs from the promoters. Subsequently, HATs, such as p300, CBP and p/CAF, arrive at the promoter region in correlation with the level of histone hyperacetylation. Although RB has been shown to bind HDACs, the contribution of RB to the deacetylation state during G0 is not clear. Instead, the interaction between RB and the histone methyltransferase SUV39H1 has been shown to be critical in modifying chromatin state, since it was shown that SUV39H1 function requires association with RB (Nielsen et al., 2001; Vandel et al., 2001) . SUV39H1 methylates K9 of histone H3 and facilitates the binding for the HP1 protein. HP1 has been suggested to play a role in establishing a heterochromatin-like state. Moreover, methylation of histones will render a promoter in a more stable repression state while acetylation can be easily reversible. Recently, SUV39H1-mediated methylation was found restricted in resting cells (Nicolas et al., 2003) , suggesting its role in sustaining cell cycle arrest. Narita et al. have noted the presence of punctuate DNA foci, heterochromatin-like structures, in senescent cells, the formation of which requires the RB pathway (Narita et al., 2003) .Importantly, the levels of me-K9-H3 increased and correlated with the recruitment of RB and HP1 to the E2F response promoters. Taken together these studies establish a critical role for the RB/E2F repressor in dampening E2F response genes in senescent cells and have identified a critical difference between resting cells and senescent cells. In resting cells, p130/E2F4-mediated deacetylation on the promoter of E2F response genes can quickly respond to growth signals whereas RBmediated methylation events stabilize senescent cells. It will be interesting to determine the significance of the role of RB tumor suppression in senescent cells. Interestingly, Ait-Si-Ali et al. (2004) showed by ChIP analysis that methylation of H3-K9 (me-H3-K9) can be detected at several E2F target promoters in differentiating cells but not in cycling cells. It can be ascertained from these studies that RB/E2F-regulated promoters undergo a permanent silencing mechanism when cells commit to terminal differentiation, although a more thorough appreciation of this mechanism remains to be elucidated.
Differential regulation by the RB family members E2F response promoters are occupied by E2F4 in complex with p107 or p130 in resting cells (Moberg et al., 1996) . This biased occupancy can be partially explained by the observation that there is an additional E2F-binding domain present in the C-terminus of RB (Dick and Dyson, 2003) . Consistently, studies in vitro show that the RB-E2F complex has relatively weak DNA-binding activity (Ray et al., 1992) . Thus an emerging model identifies RB as a harness that sequesters activator type E2Fs in early G1-or G0-phase, and results in the E2F response promoter to become occupied by repressor type E2Fs (Frolov and Dyson, 2004) . This model suggests a coregulation of E2F response genes by the RB family proteins. However, a recent study using array analysis to detect gene expression profiles in cells lacking RB or p107/ p130, revealed a distinct gene expression profile suggesting a nonredundant regulatory role governed by the RB family members (Black et al., 2003) . Specifically, genes encoding DNA replication and cell cycle regulatory proteins are found to be the signature of Rb-deficient cells. In contrast, in cells lacking p130 and p107, genes that encode proteins generally involved in the regulation of cell growth and those encoding proteins known to be involved in maintaining the extracellular matrix, are deregulated. The molecular basis for the differential expression profile remains to be explored.
E2F response gene and tumorigenesis
The E2F transcription factors, together with RB and its related proteins p107 and p130, mediate the activation or repression of genes involved in diverse cellular processes, including the cell cycle and DNA repair. Interestingly, RB remains to be the only gene in the family found to be mutated in human cancers. Genetic studies revealed the contribution of the deregulation of E2F1 and E2F3 in apoptosis and aberrant cell proliferation seen in RB deficient embryos (Tsai et al., 1998; Ziebold et al., 2001) . Recently, Lee et al. (2002) investigated how E2F4 augments RB tumor suppression. Interestingly, elimination of E2F4 suppresses the development of both pituitary and thyroid tumors in Rb þ /À mice. This study, for the first time, documented the importance of the RB/E2F complex in tumorigenesis. Careful biochemical analysis revealed that elimination of E2F4 rescued the deregulated activator-E2Fs in the absence of RB, suggesting that activator-E2Fs could significantly contribute to the tumorigenesis mediated by the loss of RB.
Regulating RB protein
We have discussed so far the lessons learned from animal model systems, in vitro cell biology, and biochemical analysis concerning the role of RB in cellular differentiation and cell cycle progression. Initially RB was envisioned to function as a negative regulator of cell cycle progression and a positive regulator for cellular differentiation. The emerging model concerning the role of RB in these diverse cellular activities is the availability of RB at G1-phase, which determines whether cells will commit to entering the cell cycle, or prepare for differentiation once the specification of a specific lineage is acquired. How cells orchestrate the diverse signals to modulate the action of RB is largely determined through post-translational modification on RB (Figure 1) . It is widely accepted that cells govern RB function through multiple CDK kinase complexes that integrate environmental cues. In the absence of growth stimuli, unphosphorylated RB binds proteins such as E2F family members, as well as corepressors, and together enable chromatin-remodeling activities. Phosphorylation of RB is specific for cycling cells and was proposed to inactivate its activity. The unphosphorylated form of RB persists in both differentiating and differentiated cells, implying its critical role in executing and maintaining proper differentiation. Recent advancements have led to the identification of the E1A-like inhibitor of differentiation 1 (EID-1) (MacLellan et al., 2000; Miyake et al., 2000) . Its potential role in RB acetylation (Nguyen et al., 2004; Krutzfeldt et al., 2005) may provide the link to the unique role of RB in cellular differentiation in comparison to its related family members.
CDK kinases
Transition between cell cycle phases is regulated by a series of temporally coordinated phosphorylation events that target members of the pocket protein family, RB, p107, and p130. The kinases responsible for pocket protein phosphorylation are cyclin-dependent kinases, which are activated in part by their association with cyclins. Several species of RB were identified by sodium dodecyl sulfate-polyacrylamide gel electropheresis (SDS-PAGE) and displayed a unique expression pattern as cells transited through the cell cycle (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989) . RB is hypo-phosphorylated in resting and early G1 cells. Progressive phosphorylation became evident when resting cells were challenged with mitogenic signals that led to the accumulation of D cyclins, which function reciprocally, to elicit the initial phosphorylation (Sherr, 1996) . Subsequently, cyclin E accumulation accounts for further phosphorylation on RB and leads to full activation of E2F1. The importance of these phosphorylation cascades was supported by observations from cancer studies, since most human malignancies have an aberration in the Rb pathway due to Cdk hyperactivation. Cancer cells bearing wild-type RB protein usually contain a highly deregulated CDK kinase pathway. For example, amplification of cyclin D and CDK4 in bypass of the requirement for growth stimuli signals, were found in a subset of cancers. Additionally, a high frequency of mutations in CDK inhibitors such as p27, p21, and INK, were found to negatively regulate CDK and promote tumor formation.
Acetylation of RB by CBP/p300 CBP and p300 are highly related proteins that serve as transcriptional co-activators for nearly every genespecific trans-activator (Eckner, 1996) . They participate in multiple regulatory networks and communicate with other co-activators and multiprotein complexes, making them co-integrators that are involved in multiple biological processes that affect cell growth, transformation and development (Goodman and Smolik, 2000) . It was proposed that EID proteins regulate differentiation by antagonizing CBP/p300 or a co-regulator of SHP (Bavner et al., 2002) . EID1, E1A-like inhibitor of differentiation, was cloned on the basis of interactions with the retinoblastoma tumor suppressor protein and was subsequently characterized as an inhibitor of CBP/ p300 dependent functions of differentiation (Miyake (MacLellan et al., 2000) . EID2 was cloned as the second member of this family and was shown to act as an inhibitor of gene expression (Ji et al., 2003) . Interestingly, it has been suggested that EID2 inhibition is a combination of two mechanisms, binding to CBP/ p300 or recruiting histone deacetylases. EID3 is specifically expressed in testis and, at the subcellular level localized to both nucleus and cytoplasm (Bavner et al., 2005) . EID3 inhibits gene expression mediated by nuclear receptors (NR), most probably by interacting with the SRC-1 interacting domain (SID) of CBP that has been implicated in co-activator assembly, thus preventing recruitment of CBP to a natural NRregulated promoter.
Of particular interest to the role of RB in differentiation, however, is its interaction with EID1. E1D1 mediates the repression of CBP/p300-dependent transactivation by sequestration of CBP/p300, TBP, and p/CAF. It contains a L Â C Â E RB-binding motif, inhibits genes regulated by a variety of nuclear receptors, and is a cofactor of the orphan nuclear receptor SHP, small heterodimer partner NR0B2 (Miyake et al., 2000; MacLellan et al., 2000) . EID1 binds Rb and p300/CBP and inhibits the MyoD target genes possibly by in part inhibiting the HAT activity of p300/CBP. EID-1 is subjected to proteasome-dependent degradation when cells exit the cell cycle possibly mediated by pRb/MDM2 and is required for normal muscle differentiation (MacLellan et al., 2000; Miyake et al., 2000; Krutzfeldt et al., 2005) . One important observation is that RB acetylation by CBP/p300 promotes its association with MDM2 and leads to the degradation of E1D-1 (Chan et al., 2001; Nguyen et al., 2004) . CBP/p300-mediated RB acetylation is unique among its family members and specifically in differentiating cells. These observations provide a novel regulation of RB activity through acetylation. Moreover, new evidence supports the binding of the RET finger protein (RFP)/tripartite motif protein (TRIM 27) to EID1 and RB, to inhibit its role as a transcriptional activator but not as a repressor, and prevents the degradation of E1D-1 (Krutzfeldt et al., 2005) . The downregulation of RFP leads to an enhanced differentiation phenotype in culture cells. Thus, a new regulatory network involving RB, critical for differentiation, is emerging perhaps through RB-mediated E1D-1 degradation regulated through CBP/p300 and RET finger proteins.
New RB regulatory network EID-1 was isolated through its association with RB. Sequence comparison between EID-1 and E1A revealed an additional conserved domain anterior to the L Â C Â E motif (Figure 2 ). This domain resides in the CR1 region of E1A and has been shown to be required for its repression of differentiation activity (Sandmoller et al., 1996) . However, whether this region is also critical for EID-1 activity awaits further analysis. As EID-1 shares a similar structure arrangement with E1A, there remains the intriguing possibility that EID proteins could evolutionarily represent the cellular origin of E1A. Moreover, since EID is quickly degraded through an RB-dependent mechanism when cells commit for terminal differentiation, viral E1A, another L Â C Â E containing protein, may compete for the L Â C Â E containing molecules for RB binding. Importantly, RB defective for L Â C Â E binding and competent for E2F binding displayed intact cell cycle regulation activity, yet, failed to induce cellular differentiation, highlighting the importance of L Â C Â E binding activity in regulating differentiation.
Several possibilities arise. First, many L Â C Â E containing proteins have been documented and each play a distinct role in various cellular processes (Riley et al., 1994) . Among them are cell cycle regulator cyclin D, transcription co-repressor CtIP, and the nucleosome disruptor BRG1. However, what other L Â C Â E containing RB-associated proteins are subject to MDM-2 associated degradation? Second, mice defective for both MDM2 and p53 develop normally although they develop a high tumor incidence later in life (McDonnell et al., 1999) . Are there E3 ligase(s) other than MDM2 involved in EID-1 degradation in the absence of MDM2? RB is known to interact with cdc27, a component of E3 ligase complex APC (Chen et al., 1995) . It will be interesting to know whether APCs are involved in the RB-dependent regulation of EID-1. The novel concept that EID-1 acts as an inhibitor of cellular differentiation urges critically the examination of its participation in the RB-regulated differentiation process.
Concluding remarks
RB seems to be a multifaceted protein with multiple functions. Until recently, the role of RB in regulating cell cycle progression and differentiation was categorized into two separate avenues: its inhibitory role on E2F response genes with an emphasis on control of the G1 to S transition, and its promotion of differentiation by activating certain tissue-specific transcription factors. However, accumulating evidence insinuates a decision-making role for RB upon encountering cellular signals (Figure 3) . In the proposed model, RB, and its family members, maintain the critical G1 juncture. Phosphorylation cascades in coordination with growth stimuli in preparation for cell division, gradually molds RB to release E2F. When cells are committed to eliciting the differentiation program, RB will be required to remove or counteract differentiation inhibitors. RB deficiency then, leads to either apoptosis for cells committed to a specific differentiation program, or uncontrolled cell growth for cycling cells.
It is clear that RB is utilized by so many processes, however, given the complexity of known RB associated proteins, the in vivo RB complex configuration remains rudimentary. To date, it is unclear how many functional RB complexes exist. It will be a great challenge to determine if RB binds E2F and EID1 simultaneously, each executing its specific function in concert with RB upon integration of cellular stimuli, or rather if the RB interacting proteins find RB separately and execute their function independently. It may be possible that a RB core complex exists while transiently associated members are recruited under specific growth and differentiation conditions in the cell. Or, perhaps there are various RB complexes, each participating in distinct processes. One of the challenges is to sort out the relative distribution of RB complexes in G0/G1-phases to elucidate the intricate RB network in regulating cell fate. 
